Accendra Health Executives Dump Shares Amid Weak Market—CEO Sells 59,000 Shares as Stock Hits 52‑Week Low
Insider sales on a weak day signal Accendra Health’s tactical portfolio shifts amid a steep decline, highlighting management’s cautious yet committed approach.
3 minutes to read

